September 2020
![](https://www.altasciences.com/sites/default/files/2020-10/Newsletter-Header_autumn.jpg)
In this issue
Examine our bioanalytical assay list, new scientific publications, webinars, podcasts, and more, covering our full-service preclinical, clinical and manufacturing solutions…
![](https://www.altasciences.com/sites/default/files/2020-10/Industry-News_Antibody-test.jpg)
![](https://www.altasciences.com/sites/default/files/2020-10/biologics-blue-small.jpg)
Key Considerations for a Successful Ligand Binding Program
Preclinical to clinical bioanalytical expertise at Altasciences
![](https://www.altasciences.com/sites/default/files/2020-10/Newsletter-092020_LP_article-2.jpg)
Challenges in Early Phase Clinical Pharmacology Studies
Importance of integration and eliminating organizational silos
![](https://www.altasciences.com/sites/default/files/2020-10/Altascientist_CNS.jpg)
The Altascientist
Central nervous system (CNS) active drugs — complex considerations.
CONTINUE READING
- Webinars
Register for upcoming complimentary webinars and view the latest ones on-demand! - Podcasts
Listen to podcasts covering industry hot topics! - Up Close and Personal with…
Meet Joseph A. Francisco - Blog
Enjoy Dr. Francisco’s commentary on the FDA guidance related to COVID-19 vaccines, and other insightful posts.
LET'S STAY CONNECTED!